Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00672074 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus
A Phase 2 study, sponsored by Helsinn Therapeutics (U.S.).
- Completed
- Registry status
- Phase 2
- Development phase
- 117
- Enrollment target
NCT00672074 is a Phase 2 study that has completed, run by Helsinn Therapeutics (U.S.). The registered enrollment target is 117 participants.
The verdict
NCT00672074, a Phase 2 study, has completed, sponsored by Helsinn Therapeutics (U.S.).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 117 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if ipamorelin is safe and effective in the management of post-operative ileus.
Interventions
- DRUG placebo
- DRUG Ipamorelin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00672074
The ClinicalTrials.gov registry entry for NCT00672074 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Helsinn Therapeutics (U.S.), which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00672074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00672074 about?
NCT00672074 is a clinical study titled "Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus". The purpose of this study is to determine if ipamorelin is safe and effective in the management of post-operative ileus.
What is the current status of trial NCT00672074?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 117 participants. The study started on 2008-04. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00672074?
The interventions under investigation include: placebo (DRUG), Ipamorelin (DRUG).
Who is sponsoring clinical trial NCT00672074?
This trial is sponsored by Helsinn Therapeutics (U.S.), which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.